Media Mentions

Warrington mother of two Louise Hulme, who flew to America for life-saving surgery to remove a stage four brain tumor, is now preparing for phase two of her journey.

Last year, while serving on the frontlines against COVID-19, Ian Youngblood was diagnosed with glioblastoma. Now, Ian is back in Arizona and doing what he loves which includes teaching yoga classes, hiking and motivating everyone around him. On Saturday, May 29, Ian led a charity class in Scottsdale, AZ to support the cutting-edge research happening at the Ivy Brain Tumor Center.

Just five weeks after his fourth child was born, Tim Jackson, a 43-year-old nurse from Arizona, was diagnosed with brain cancer. Tim and his wife, Amber, remain optimistic as he participates in a new Ivy Phase 0 clinical trial for newly diagnosed glioblastoma.

Louise and her husband Kev continue to manifest hope and overcome challenges in the face of a glioblastoma diagnosis. Traveling from the United Kingdom to the United States to participate in an Ivy Phase 0 clinical trial, Louise is determined to fight like a true brain tumor warrior.

In the latest edition of CURE magazine's Clinical Trial Corner, the Ivy Center's first-in-human clinical trial of noninvasive sonodynamic therapy for recurrent brain cancer was highlighted.

A promising non-invasive treatment to effectively and safely destroy deadly brain tumors is being tested on human patients for the first time ever at the Ivy Brain Tumor Center at the Barrow Neurological Institute in Phoenix.

Earlier this year, the Ivy Brain Tumor Center received FDA approval for a Phase 0 clinical trial to study a first-in-human drug-device combination that uses MRI-guided focused ultrasound in combination with aminolevulinic acid to selectively target and kill tumor cells. Peter Hofland of Onco'Zine covers the story in this article and what it could mean for the brain tumor community.

Dr. Nader Sanai, director of the Ivy Brain Tumor Center, says although the survival rate is low it doesn't mean there isn't hope to beat cancer. "These are populational statistics, they don't describe you or predict your future." He and Youngblood are teaming up to bring awareness to the disease for Glioblastoma Awareness Day. Sanai says a day focusing on brain cancer is important because it hasn't seen the same progress in therapies like breast or prostate cancer.

Chamber Business News highlights the Ivy Brain Tumor Center's resilience in fighting brain tumors despite the pandemic and the importance of Glioblastoma Awareness Day. Observed as a day to honor those who have been impacted by the disease, the initiative also supports efforts to develop better treatment options that will improve patients’ long-term prognosis.

The Arizona Republic shares the story of Ian Youngblood, a 29-year-old nurse from Arizona who received a harrowing diagnosis of glioblastoma while helping fight COVID-19 on the frontlines in NYC. Dr. Nader Sanai weighs in on why these types of tumors are so hard to control and what it will take to move the needle on identifying new, effective treatment options.